Published ahead of print on June 10, 2004, doi:10.1165/rcmb.2004-0089OC
Am. J. Respir. Cell Mol. Biol., Volume 31, Number 3, September 2004, 283-291
A more recent version of this article appeared on September 1, 2004
Submitted on March 15, 2004
Revised on June 9, 2004
Molecular Regulation of IL-13 and MCP-1 Expression in Human Mast Cells by IL-1
Steven A Lee1, S. Matthew Fitzgerald1*, Shau K Huang2, Chuanfu Li3, David S Chi1, and Guha Krishnaswamy1
1 Department of Internal Medicine, East Tennessee State University, Johnson City, Tennessee, USA,
2 Department of Surgery, East Tennessee State University, Johnson City, Tennessee, USA,
3 Asthma and Allergy Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
* To whom correspondence should be addressed. E-mail: mattfitzgerald1{at}aol.com.
Mast cells play pivotal roles in IgE-mediated airway inflammation, expressing interleukin-13 (IL-13) and monocyte chemoattracant protein-1 (MCP-1), which in turn regulate IgE synthesis and/or inflammatory cell recruitment. The molecular effects of interleukin-1 beta (IL-1 ) on cytokine expression by human mast cells have not been studied well. In this report, we provide evidence that human mast cells express the type 1 receptor for IL-1 (IL-1R1). We also demonstrate that IL-1 and tumor necrosis factor alpha (TNF- ) are able to induce, individually or additively, dose-dependent expression of IL-13 and MCP-1 in these cells. The induction of IL-13 and MCP-1 gene expression by IL-1 was accompanied by the activation of IL-1 receptor associated kinase (IRAK) and translocation of the transcription factor, nuclear factor kappaB (NF- B) into the nucleus. Accordingly, Bay 11-7082, an inhibitor of NF- B activation inhibited IL-1 -induced IL-13 and MCP-1 expression. IL-1 also induced IL-13 promoter activity, while enhancing the stability of IL-13 mRNA transcripts. Dexamethasone, a glucocorticoid, inhibited IL-1 -induced nuclear translocation of NF- B and also the secretion of IL-13 from mast cells. Our data suggests that IL-1 can serve as a pivotal co-stimulus of inflammatory cytokine synthesis in human mast cells, and this may be partly mediated by IL-1 receptor-binding and subsequent signaling via nuclear translocation of NF- B. IL-1 being a ubiquitously expressed cytokine, these findings have important implications for non-IgE-mediated signaling in airway mast cells. This could have important implications for innate immunity and airway inflammatory responses, such as observed in extrinsic and intrinsic asthma.
This article has been cited by other articles:

|
 |

|
 |
 
C. A. Hudson, G. P. Christophi, R. C. Gruber, J. R. Wilmore, D. A. Lawrence, and P. T. Massa
Induction of IL-33 expression and activity in central nervous system glia
J. Leukoc. Biol.,
September 1, 2008;
84(3):
631 - 643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Swaisgood, M. A. Aronica, S. Swaidani, and E. F. Plow
Plasminogen Is an Important Regulator in the Pathogenesis of a Murine Model of Asthma
Am. J. Respir. Crit. Care Med.,
August 15, 2007;
176(4):
333 - 342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang, M. Adner, and L.-O. Cardell
IL-1beta-Induced Transcriptional Up-Regulation of Bradykinin B1 and B2 Receptors in Murine Airways
Am. J. Respir. Cell Mol. Biol.,
June 1, 2007;
36(6):
697 - 705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Lockwood, P. Matta, G. Krikun, L. A. Koopman, R. Masch, P. Toti, F. Arcuri, S.-T. J. Huang, E. F. Funai, and F. Schatz
Regulation of Monocyte Chemoattractant Protein-1 Expression by Tumor Necrosis Factor-{alpha} and Interleukin-1{beta} in First Trimester Human Decidual Cells: Implications for Preeclampsia
Am. J. Pathol.,
February 1, 2006;
168(2):
445 - 452.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 American Thoracic Society.
|
|
|